[10/6 10th Fraud Countermeasures Study Session] What if corporate fraud occurs tomorrow?Former President Editor-in-Chief talks about “Three ways to become a company that is strong in dealing with scandals”
In this study session, we will invite Kenichi Ogura, an economic journalist and director of the Itomos Institute, to teach us specific ways to protect organizations while using real-life examples.
[Date and time] September 2023, 10 (Friday) 6: 16-00: 17
[Participation conditions]
We kindly ask that you refrain from applying if you are using the free address, if you are in the same industry as us, or if you do not know your affiliation.When accessing Zoom on the day, please enter your name and email address that you entered at the time of application in the entry field for Zoom participation.
Director of Economic Journalist Itmos Institute
Born in 1979.After graduating from the Faculty of Economics at Kyoto University, she worked as a secretary for Yuriko Koike, then a member of the House of Representatives, before joining President Inc. In 2020, she became the youngest editor-in-chief of an economic magazine at the time, and has also served as a judge for the Economic Public Relations Center (Keidanren) Corporate Public Relations Award.He interviewed over 100 of Japan's top leaders, including Kazuo Inamori, Masayoshi Son, Tadashi Yanai, Buffett, Akio Nitori, Hiroshi Mikitani, Toru Hashimoto, Yoshihide Suga, Yuriko Koike, and Isao Iijima.Currently, he is involved in writing activities and supporting corporate public relations at the Itmos Research Institute, which he founded.He has been ranked first in the overall access ranking of Yahoo News 1 times (15). (Titles omitted)
FRONTEO Inc.
Director / AI Solution Business Management and President's Office Manager
Mari Yamamoto
After joining an advertising agency, she was enrolled in a risk management company.Launch the mental health care business, execute business plans, product development, marketing, and sales strategies, and lead to the top market share in the industry. In 2014, she became a director of the company and was listed on the First Section of the Tokyo Stock Exchange in 2017.
Joined FRONTEO Inc. in December 2018 and became a director in 12, managing and directing the entire AI solution business.
In the life science AI business, we are promoting development in the digital health field such as diagnosis support and disease prediction using the AI engine "KIBIT", and in the drug discovery field, we will greatly improve the efficiency of drug discovery research by fusing AI and drug discovery researchers. We will develop businesses that support the development, acceleration, and improvement of the probability of success, and challenge new areas in life science.
In the business intelligence business, he uses KIBIT to lead corporate DX promotion support.We will also develop AI-based solutions in the economic security field to support governments, public offices, and companies.
Articles in the same category
[Online seminar held on 5/30] Practical techniques for legal due diligence for M&A
[5/31 15th Fraud Countermeasures Study Session] [Must-see for compliance personnel] Mass media response in the event of a crisis
[Online seminar held on 5/9] New framework and practical outlook for European foreign investment regulations - Explanation of the European Commission's new regulation proposal and the regulatory environment of major countries -
[Real seminar held on 4/18] “Crisis management proposed by a competition law/consumer law boutique firm” ~Risk management to avoid a “crisis”~
Exploring patient stratification biomarkers for IgA nephropathy using AI: Overcoming bias with AI
Searching for therapeutic targets for pancreatic cancer - I tried using paper search AI -
Parkinson's disease - Analyzing drug discovery targets using paper search AI
Economic Security Symposium co-hosted by FRONTEO x Moody's Analytics Japan on April 4th
Searching for new targets for sporadic ALS using AI: Become friends with AI